Mikhail Blagosklonny, Perfecting Oncology as a Discipline

We all must have gotten sick at one point in our lives, but at every instance, we were most fortunate to find a remedy to our disease. To this end, it is paramount that we get to appreciate the role that technology and innovation play in our day to day lives. Without the two, then cures for particular diseases would still evade us in equal measure. Today, scientists can gloat and boast of finding cures for illnesses like cancer, typhoid, and even much-dreaded cholera. Despite all the medical breakthroughs, the remedy for cancer has evaded us for generations, but thanks to an individual like Mikhail Blagosklonny, all is not lost.

For a long time, Mikhail has been overly concerned about the relationship between cancer and aging. As a researcher, he has always found the relationship between the two aspects fascinating, something that has given him a basis for his scientific investigations. Although such a journey has always been challenging, there has never been much reason for Mikhail Blagosklonny to give up. As an educated fellow and university professor, Mikhail has always found it meaningful to share his findings with his many students and the rest of the world. Mikhail believes that even if he might not be able to find a cure for cancer in his lifetime, his research work will help young scientists find a remedy to the disease in future and more information click here.

Another thing that has always been of great concern to Mikhail Blagosklonny is access to quality health care at affordable rates. For many years, Mikhail has watched only the wealthy people in society find quick access quality treatment procedures, particularly for cancer. On the other hand, the needy individuals have always died in agony since they lacked the resources to foot expensive medical bills. Blagosklonny has always looked forward to the day he will find a safe and reliable cure for cancer. According to Blagosklonny, such a moment will be a point in time when cancer patients from low-income families will start getting sound treatment at highly affordable rates and his Linkedin.

In as far as aging is concerned; Rapamycin has been the only drug in use for slowing down the aging process. For a long time, scientists have found aging as the leading cause of diseases among the seniors, allegations that have gained solid backing from scientific investigations over the years. However, what the world did not know is that Rapamycin is also suitable for treating cancer. Based on Mikhail’s scientific findings, Rapamycin eliminates the disastrous effects of cancer only when administered in the right proportions. By slowing down aging, Rapamycin, first of all, reduces the chances of you contracting cancer. Secondly, Rapamycin stimulates the healthy stem cells in your body to fight the cancerous ones, leaving you healthy and active in the process. Although tests for Rapamycin concerning cancer are still in their pilot stages, there lies much hope that the world will get saved once and for all. If it were not for Mikhail Blagosklonny, we would not have reached this far. Therefore, we can still see the light at the end of the tunnel and read full article.

How Dr. Jennifer Waldens Juggles Between Family and Her Demanding Profession

Dr. Jennifer Walden ranks as one of the most sought-after medical experts in the field of cosmetic surgery. She is accredited by the body that is charged with the mandate of certified plastic surgeons, the American Board of Plastic Surgery. Dr. Jennifer Walden is not only experienced in conducting cosmetic procedures such as rhinoplasties and face-lifts, she well qualified academically.

Dr. Jennifer is also affiliated with medical societies in the field of cosmetic surgery such as the American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons. Several reputable publications such as the Texas Monthly have previously listed Dr. Jennifer Walden as a Texas Super Doctor. In the year 2016, Jennifer got the rare opportunity of becoming a member of the American Association of Plastic Association.

Dr. Jennifer Walden has not only excelled in her profession but also in matters family. She is an adamant proponent of proper parenting given that she had to relocate her practice to Austin, Texas so that she could be closer to her twin sons and what Dr. Walden knows.

Jennifer Walden has covered a lot of cosmetic surgery fields in a study and her practice. She possesses a lot of knowhow on topics such injectables for soft tissues, minimally invasive cosmetic surgery, breast and hip augmentations, rhinoplasties and face-lifts. She has undertaken plastic surgery procedures on a good number of individuals including celebrities and high net-worth individuals. In the mainstream media, Jennifer has proved to be a good commentator on matters cosmetic surgery and many media outlets are always ready to invite her on set when they have to discuss anything to do with this field of medical science.

Dr. Jennifer Walden boasts not only an impressive career but also a life of giving back to the society. She always encourages her patients to love themselves after cosmetic surgery and to appreciate how unique they look and read full article.

More Visit: http://www.austinmdmagazine.com/an-austin-girl-comes-home-dr-jennifer-l-walden/

Clean Water on Better Terms with Waiakea Bottled Water

There are many fast growing companies around the world at the moment. There is even a separate ranking system for these businesses whose growth is inspiring to their peers. Waiakea Bottled Water ranks at number 414 on the list. Their business venture has proved to be successful, and they are on the same list together with companies such as Zappos and GoPro. These brands may be better known than Waiakea, but the bottled water brand sees it only as the beginning of their climb to worldwide recognition.

Company Growth Gets Celebrated

In a short period of two years, the company grew by 1,059 percent becoming the best-bottled water. Inc. 5000 honors these unique companies every year in a conference which happens in California. It celebrates the growth of enterprises as well as their contribution to society.

Ryan Emmons is steering the ship of Waiakea Bottled Water as their CEO, and he expresses his joy about the significant achievement. Inc. 5000 list has only elite companies in it, and every new business wants to be on the list. He said that the firm is very proud, but they are not going to stop at that. They want to continue work on innovation for the brand to make it even better.

Grow to Help Others

Waiakea Bottled Water has a good business ethic, and they follow a strict moral code. They want to be eco-friendly and healthy. They are inspiring other companies to follow the same standard.

The company dates back to 2012. They started out as the only volcanic water brand. They celebrated their Hawaiian heritage and also wanted to give back to others. The company not only produces water, but they also work on innovation in this line of business too. The packaging is sustainable and recyclable. Waiakea works on making clean water accessible to people in countries where water is a luxury. They believe that places, where the water supply is plentiful, should help to end thirst in Africa. The company donates 650 liters of water for every liter they sell. That comes to a total of about 5 percent of their revenue. They partner with Pump Aid to create more water pumps for people in Africa.

A Look at Dr. Avi Weisfogel’s Achievements in Medicine

Dr. Avi Weisfogel is a celebrated and famous doctor who is well-known for his advancement in the treatment of sleep disorders. A psychology and biology graduate of Rutgers University with DDS in dentistry from NYU’s college of dentistry. He took an extra to study dental sleep medicine which formed the basis of his business model. This course enabled him to use his business model to bridge the gap between dentistry and sleep disorders.

Dr. Avi Weisfogel struggled for the first ten years after he established his business. He mostly utilized this time to obtain valuable experiences even as he tried to get referrals and keep his venture afloat. He is considered a pioneer in using sleep technology to design appropriate methods of treating sleep disorders. The pioneering research he conducted has been the source of treatment to many patients worldwide, coupled with the advancement of dental sleep medicine.

Dr. Weisfogel used the Unlimited Sleep Patient as a conduit to share his knowledge with other doctors on how to effectively treat and handle sleep disorder and dentistry. He taught them how to diagnose and treat sleep disorders. His knowledge and understanding of sleep disorders are the bedrock of the treatment of a disease that has plagued humanity for a long time. The good doctor shares his experience of more than twenty years, through the Healthy Heart Sleep a medium he uses to collaborate with other medical professionals.

His desire for the welfare of his patients led him to establish Dental Sleep Masters, a creative business to treat complications related to dentistry and sleep disorders. His business acumen plus experience in marketing gave him the impetus to launch an exceptional invention in the history of medicine. Dr. Weisfogel uses oral appliances to treat his patients with obstructive sleep apnea. His innovations and treatment approach has endeared him to medical professionals all over. He is regarded as the enigma of sorts because his methods help doctors understand conditions like sleep apnea and its associated complications.

One of his strengths is the desire to go the extra mile especially on the success of other physicians. The design of the sleep medicine program is so comprehensive to include phones calls, daily text messages or emails, webinars on a monthly basis and retreats four times a year.

No One Wants Money In Politics, So Why Is It There? ECU’s Fight For Justice

Republicans and Democrats (mostly) both agree that money in politics is bad. Despite almost universal opposition, however, corporate interests continue to make a significant impact on American elections. The 2016 election showcases how intertwined the private sector and government currently are. Not only did a businessman billionaire win office, but his only relevant opponent was also a common target of criticism in regards to corporate corruption. Unfortunately, a number of passionate members of the political process were isolated by the General Election’s transformation into a Hillary vs. Trump affair.


But not everyone has submitted to pessimism and defeat. Instead, political action groups like End Citizens United (ECU) have stood up after the temporary defeat of 2016 and continue to wage war against corporate influence in politics. End Citizens United dedicates their mission to fighting against political corruption, and their primary objective is to eventually reverse or terminate the Supreme Court’s 2008 decision on the Citizens United case. Citizens United is, in many ways, the exact type of financial corruption that members of ECU and similar organizations loathe so intensely. Due to Citizens United, political contributions cannot be restricted and are therefore unlimited. The Supreme Court’s opinion on the Citizens United case essentially equates people to corporations, and in the minds of ECU, this comparison is faulty and results in injustice.


ECU doesn’t limit their battle to corporate corruption, though. Just recently, ECU, along with organizations Every Voice, Common Cause, and Daily Kos, sent 300,000 petitions to the Department of Justice. These petitions demand an investigation into Russian’s alleged interaction with the 2016 general election. This effort represents the broader issue that ECU seeks to illuminate and eliminate: unethical practices within government. Money in politics is an enormous ethics issue within America, but ECU tackles anything that threatens the integrity of our governing body.


Fortunately for those desperate for change, ECU is doing remarkably well at raising money. According to a USA Today article, ECU raised $4 million during the first quarter of 2018. If ECU continues this pace, they project their earnings will total $35 million before the beginning of midterms. This is a grassroots movement, with the average contribution coming in at around $12. 100,000 have donated, and 40,000 were first-time donators, which suggest an upswing within ECU. For those angry with the results of the 2016 election and the continued corruption of politics, End Citizen United serves as a viable outlet to put energy towards: their efforts are making an impact, and with help, they can make a sizable dent on the outcome of the 2018 midterms.

The Distinguished Lawyer; Jeremy Goldstein

In our daily occurrences, we may need an attorney who can handle our child custody issues, legal issues or even help in writing a will. Looking for one can prove tedious, that is why the New York State Bar Association trusted Lawyer Referral and Information Service (LRIS) has come up with a more convenient way of seeking for lawyers. It has created an online portal for people who are looking for attorneys. LRIS has assured individuals that they will be matched with attorneys that have the relevant experience and apt credentials, which have been verified by the New York State Bar Association.


The online service is quite straightforward. The person in need of the lawyer’s services accesses the website where he or she fills out a private questionnaire with a description of the kind of legal aid they need together with their location. The ball gets to the State Bar staff who review the survey and matches the potential client with an attorney that has an office in the community. The referrals are not payable. Once the customer talks to the lawyer they have been referred to, a fee of $35 is applicable for the first half hour of consultation. After the first consultation, one may retain the attorney at their own will. If this happens, the additional fee is agreed upon by the lawyer and the client.


Jeremy Goldstein is a New York-based attorney who has practiced for more than 18 years. He has rendered services to individuals, corporation as well as businesses. The residents of New York City have enjoyed his services. Jeremy Goldstein is managing partner at Jeremy Goldstein Associates.


Jeremy Goldstein studied at the Cornell University of Chicago and later attended the New York University of Law. He began his career at Shearman and Sterling LLP. He worked there for a year before joining Wachtell, Lipton, and Rosen & Katz as a partner. Jeremy Goldstein is listed on the LRIS portal.


Visit http://jlgassociates.com/ for more details.

Luiz Carlos Trabuco Completes Largest Purchase In Bradesco history

Over the past two decades, the Brazilian banking industry has followed the lead of many of its global counterparts. The trend towards consolidation has been unstoppable, with only two real players emerging as the leaders of the country’s banking system, having gobbled up almost all of their viable competitors. Those two banks are Itau Unibanco and Bradesco.

Since taking over in 2009, Bradesco’s CEO, Luiz Carlos Trabuco, had been looking for a suitable acquisition target. While the Brazilian banking system had experienced phenomenal growth over the decade of the 2000s, that organic growth had slowed by 2009. Since then, the industry has stagnated, with many banks actually declining in revenues. In this environment of stagnating growth and declining profits, Trabuco saw the only way his bank had any chance of catching up with its larger competitor was through strategic acquisitions. The problem was that almost all the good targets had already been acquired.

Then, in 2015, rumors started swirling that HSBC, the second largest private bank in the world, was looking to dump its Brazilian assets. Word on the street was that the global firm had been heavily losing on its Brazilian operations and wanted out for good. Trabuco jumped on the case, immediately reaching out and beginning talks with HSBC higher-ups about a possible acquisition. By the middle of 2015, it became clear that a deal was in the works.

Read more on Crunchbase.

By late 2015, Bradesco had made official announcements that it would complete the all-cash purchase of HSBC Brazil by the end of the year for $5.2 billion, marking the largest business transaction in the history of Bradesco. Upon completion of the deal, Trabuco was awarded the Isto E Dinheiro Entrepreneur of the Year Award. He was also lauded in the media for having instantaneously grown his company, with one single transaction, from a distant second place to a serious competitor for the status of largest bank in Brazil. It was a great triumph for Bradesco.

Today, Bradesco is one of the largest Brazilian financial institution in a number of measures. In fact, they come out ahead of Unibanco on almost every measurement of success except for total assets. Bradesco has the largest number of branches in Brazil, at over 5,000. They also have the highest amount of assets under management, the largest number of account holders and the highest deposit amount from retail customers.

This is more than just a vanity contest for the respective banks’ executives. In the current de facto duopoly market, the firm that ultimately comes out on top has a road to becoming the undisputed leading bank in Brazil. That is likely to come with many rewards, including monopoly pricing power across many different products. In a stagnating market, where no real growth has occurred in the better part of a decade, this zero sum game of winner-take-all may be the only way for either one of the two firms to actually create value for their shareholders.

Given Luiz Carlos Trabuco’s long history in upper management and his formidable experience in the banking industry, it would be a good bet that he and Bradesco are poised to come out on top. And the stakes could not be higher.

But Luiz Carlos Trabuco Cappi is circumspect about his ambitions. He says that his real goal is only to provide the best possible customer service to the bank’s clients and that getting to be the largest bank in Brazil is not a major goal in itself. Time will tell.

Learn more about Luiz Carlos Trabuco Cappi: https://relationshipscience.com/luiz-carlos-trabuco-cappi-p3489986

Dr. Andy’s Expertise as a Physician at Life Line Company

Life Line Screening company was first established in 1993. Its main role was to promote wellness and prevention against epidemics. The company is found in Austin, TX, and serves many parts of the United States with screening services. Lifeline Screening expanded its scale of operation in 2007 by introducing Finger-Stick Blood testing procedure. The procedure has successfully managed to attract several patients with concerns about their cholesterol count, inflammations, and Diabetes. According to the report released by the management, Life Line Company has screened over 8 million people since it started and Life Line Screening’s lacrosse camp.

The Chief Medical Officer at Life Line, Dr. Andy Manganaro, has served in the company for a long period. He has successfully participated in several medical procedures within the company. He explains the highlights that the number of people seeking medical care at Life Line is sharply increasing. As a result of this trend, Life Line has managed to gain national recognition for the screening of vascular conditions. Dr. Andy particularly reviews ultrasound and is also in charge of quality assurance, clinical marketing, as well as medical research and learn more about Life Line Screening.

Moreover, Dr. Andy chairs Scientific Advisory Network, a group that comprises of medical practitioners and academicians from a global reach. Life Line Company applies technological algorithms to find out the suitability of screening a patient. This has enhanced safety and mitigation of risks that present with the screen of cardiovascular diseases. For this reason, many people have settled for a screen at Life Line.

Life Line regularly markets the benefits of its services through print and various other Life Line databases. Use of technology and intensive research are among the selling points of Life Line Company services. Apparently, the company provides several services that include non-invasive Ultrasounds of the abdominal aorta and carotid arteries as well as tests for peripheral vascular diseases through ankle brachial index measurement.

In summary, Life Line Company has broadened its scale of operation and now offers non-invasive osteoporosis screening together with other abnormalities. Dr. Andy has gained a wide scope of experience in several screening processes and holds a record of competence with endless possibilities of accomplishing more at Life Line Company and more information click here.

Amicus Therapeutics: a Biopharmaceutical Company that Offers Cutting-edge Solutions

Amicus Therapeutics is an American pharmaceutical company whose headquarters is in Cranbury, New Jersey. This company was formed in 2002, and its chief executive officer is John Crowley. Amicus Therapeutics is a public company and was listed on NASDAQ in 2007. Other key officials in the company include Bradley Campbell, who serves as the chief operations officer, and William Baird, who is the chief financial officer. Amicus Therapeutics boasts over a million dollar net worth and has over 100 employees. This firm has survived economic downturns and continues to conquer new markets while developing world-class products.


About Amicus Therapeutics


Amicus Therapeutics conducts research on rare diseases, which are commonly known as lysosomal storage disorders. This company manufactures products based on the Chaperone-Advanced Replacement Therapy (CHART). For years, this company has focused its resources on the development of enzyme replacement therapies (ERTs). Amicus Therapeutics was recognized in 2014 for possessing a broad range portfolio of pharmacological chaperones in the biopharmaceutical industry. This company’s most popular product is migalastat commonly known as Galafold, which is used in the treatment of Fabry diseases. This compound is designed to stabilize endogenous mutant galactosidase compounds. Amicus Therapeutics has also worked in collaboration with the major players in the pharmaceutical industry, including JCR Pharmaceuticals and GlaxoSmithKline. This cooperation was aimed at researching on co-formulation of the conjugate alpha-galactosidase. In 2008, Amicus Therapeutics moved its operations from New Jersey to a facility in San Diego.


Amicus Therapeutics source of funding


This company extraordinary works have been recognized globally, and in 2010, Amicus Therapeutics received $500,000 in research grants. This funding was issued by the Michel J (GoogleFinance). Fox Foundation to support a collaborative research with David Geffen School of Medicine at UCLA. Amicus Therapeutics is also the recipient of the $210,300 grant, which was issued by the Alzheimer’s Drug Discovery Foundation. Other donors that have funded this company include Canaan Partners, Radius Ventures, and New Enterprise Associates. Amicus Therapeutics has tried to expand its business across the United States. In 2013, it acquired Callidus Biopharma. This acquisition led to the obtaining of a replacement therapy used to treat Pompe Disease. Amicus Therapeutics also purchased Scioderm in 2015 for $947 million.

More of Amicus Therapeutics at Facebook | Twitter | Crunchbase

How Mike Baur Works with Investors to Support ICT Based Startups.

Mike Baur is Swiss businessman who is recognized for his success in the investment and banking industries. He has been committed to offering advice and financial aid to innovative entrepreneurs who have established businesses that provide excellent ICT Solutions. Baur was born in the Fribourg area, and he is currently a resident of the Zurich. He has always been passionate about banking, and this enabled him to have a successful career in the sector. Mike served major banking institutions during his two-decade career in the field, and they include Clariden Leu and UBS. In 2014, he decided to venture into investment and created the Swiss Startup Factory together with Max Mister and Oliver Walzer. Baur currently acts as the managing partner of the enterprise. The Swiss Startup Factory is recognized for being a pioneer company that offers business acceleration programs by using privately sourced funds.


To date, the Swiss Startup Factory has worked with different business leaders in investing millions of dollars in innovative startups. He has teamed up with various private investors who guide the young entrepreneurs on how they can be successful in the business world. Mike has also been working in close collaborations with various organizations that are devoted to ensuring the success of new ventures. He is among the directors of Swiss Startup Foundation, which is a body that he participated in establishing. The entrepreneur was on the jury of the START Summiteer. The event was organized by the University of Gallen to serve a challenge of startups. Mike has been acting as a deputy MD of the CTI Investment since 2016 when the company formed a partnership with the Swiss Startup Factory.


Mike has excellent academic accomplishments. He currently holds an MBA and an Executive MBA. The Wall Street Journal recognized his career achievements and wrote a story about his success in the Swiss banking sector, investments in ICT startups, and his journey as an entrepreneur. The Swiss Startup Factory has made Mike Baur manage all its financing undertakings. He is in charge of sourcing funds for the company by convincing investors to support ICT-based startups. SSUF has offered resources to ensure that young businesses grow and build a niche in the corporate world. The company has also been providing its aid to high potential enterprises that have already been established but lack sufficient funds to expand. It determines outstanding startups by conducting searches across the country.